News

AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the advantages of patients across the U.S. as well as around the world. This $445 million...

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Over the past decade, Ireland has seen a significant rise in demand for non-surgical cosmetic treatments — and at the forefront of this trend are anti-wrinkle injections. Once associated primarily with celebrities and the ultra-wealthy, these treatments are now...

Introduction In pharmaceutical manufacturing, every degree matters. Process cooling is not merely a support function—it's a critical control point that directly impacts product stability, batch consistency, and regulatory compliance. As the UK and European pharmaceutical industry continues to evolve with...

Datroway, a cancer drug developed by AstraZeneca and Daiichi Sankyo, has demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in the TROPION-Breast02 Phase III trial. The...

Lonza widens cell and gene therapy suite by way of launching of two new products, which are - TheraPEAK AmpliCell Cytokines as well as TheraPEAK 293-GT Medium. The additions happened to be aimed at elevating the scalability as well as...

The Food and Drug Administration (FDA), which is already reeling from the layoffs and leadership changes within the Trump Administration, has warned that the government shutdown is also going to delay or pause a significant amount of work at...